Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

C B Toscano E

48 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Clinical Trial 19 Mechanism of Action 17 Depression 17 Safety 14 Review Article 13 Receptor Pharmacology 13 Addiction 11 Observational Study 10 Wellbeing 9 Systematic Review 9 Healthy Volunteers 8 Anxiety 8

Journals

ClinicalTrials.gov 12 Metabolic engineering 4 Journal of psychoactive drugs 3 Metabolic Engineering 2 C&EN Global Enterprise 2 Journal of psychopharmacology (Oxford, England) 2 Journal of Psychopharmacology 1 medRxiv 1

Publication history

Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-09-01 Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworksJournal of Psychopharmacology · 2026-08-17 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and ColoradomedRxiv · 2026-08-12 Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17 Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyClinicalTrials.gov · 2026-07-02 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02 Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic ReviewPsyArXiv · 2026-05-24 Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2026-03-01 Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.Journal of clinical psychopharmacology · 2026-01-01 Is there more to magic mushrooms than psilocybin?C&EN Global Enterprise · 2025-10-19 "Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.Toxicon: official journal of the International Society on Toxinology · 2025-09-01 Psilocybin biosynthesis enhancement through gene source optimization.Metabolic engineering · 2025-09-01 “Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushroomsToxicon · 2025-09-01 Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.CNS drugs · 2025-09-01 A Scoping Review of Research in Naturalistic Studies with Psychedelics.Journal of psychoactive drugs · 2025-06-28 Visual Surround Suppression and Perceptual Expectation Under PsilocybinClinicalTrials.gov · 2025-06-27 Long-term benefits of single-dose psilocybin in depressed patients with cancer.Cancer · 2025-06-15 Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseClinicalTrials.gov · 2025-05-16 The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-05-01 Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-25 Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Progress in neuro-psychopharmacology & biological psychiatry · 2025-03-20 Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.Expert opinion on drug discovery · 2025-02-03 Impact of psilocybin on cognitive function: A systematic review.Psychiatry and clinical neurosciences · 2024-12-01 The Effects of Psilocybin on Shared Experience in Film ProcessingClinicalTrials.gov · 2024-09-27 In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.Psychopharmacology · 2024-06-01 Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-05-01 Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.Journal of psychoactive drugs · 2024-01-01 Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of DepressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19 Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01 Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersClinicalTrials.gov · 2023-05-19 Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20 The History, Legalization and Potentials of Psilocybin-Assisted PsychotherapyJournal of Scientific Exploration · 2023-02-11 Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01 Psychedelics’ binding depends on receptor mutationsC&EN Global Enterprise · 2022-09-01 Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.Metabolic engineering communications · 2022-06-01 Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-15 The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01 Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01 Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives.Metabolic engineering · 2020-07-01 Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.Frontiers in psychiatry · 2020-01-01 In vivo production of psilocybin in E. coli.Metabolic engineering · 2019-12-01 Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.Metabolic engineering · 2018-07-01 Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.International journal of cardiology · 2009-05-01

Author directory